Regulatory News
Thursday, July 21, 2016
BRIEF-Amgen and UCB submit biologics license application for romosozumab to the FDA
* Amgen and UCB submit biologics license application for
romosozumab to the FDA
Read more
No comments:
Post a Comment
‹
›
Home
View web version
No comments:
Post a Comment